Immuron (IMRN) Return on Assets (2018 - 2025)
Immuron (IMRN) recorded quarterly Return on Assets of 5039936256.33% in Q3 2025, up 119.26% quarter-over-quarter from 2298576329.98% in Q2 2025, and up 503993625633.0% on a YoY basis from N/an in Q3 2024.
Immuron (IMRN) Return on Assets (2018 - 2025) Analysis & Trends
Immuron's Return on Assets history runs 8 years deep, the most recent figure standing at 5039936256.33% for Q3 2025.
- In Q3 2025, Return on Assets rose 503993625633.0% year-over-year to 5039936256.33%; the TTM figure through Sep 2025 stood at 5039936256.33% (up 503993625633.0% YoY), while the FY2025 annual figure was 0.01%, down 1.0% from the prior year.
- Return on Assets was 5039936256.33% for Q3 2025 at Immuron, up from 2298576329.98% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 5039936256.33% in Q3 2025 to a low of 0.0% in Q4 2023.
- Historically, Return on Assets has averaged 816489249.64% across 5 years, with a median of 0.0% in 2021.
- The sharpest annual moves came in 2021 and 2025: Return on Assets changed 0 bps in 2021, then jumped 2000000000 bps in 2025.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then surged by 77 bps to 0.0% in 2022, then slumped by 29056 bps to 0.0% in 2023, then soared by 2000000000 bps to 4092336908.65% in 2024, then advanced by 23 bps to 5039936256.33% in 2025.
- The last three Return on Assets figures came in at 5039936256.33% (Q3 2025), 2298576329.98% (Q2 2025), and 4092336908.65% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -0.01% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.01% |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 5,039,936,256.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 5,039,936,256.33% |
| Jun 30, 2025 | 2,298,576,329.98% |
| Dec 31, 2024 | 4,092,336,908.65% |
| Sep 9, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 28, 2023 | 0.00% |
| Aug 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Aug 31, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 1, 2020 | 0.00% |
| Jun 30, 2020 | -0.01% |
| Dec 31, 2019 | -0.01% |
| Jun 30, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |